| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Mouse |
| Target | VAP-1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| | |
Vepalimomab is an experimental mouse monoclonal antibody intended for the treatment of inflammations. It blocks vascular adhesion protein 1. Development of the drug was discontinued in 2002.
Monoclonal antibodies for the immune system | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immune system |
| ||||||||||
| Interleukin |
| ||||||||||
| Inflammatory lesions |
| ||||||||||
| |||||||||||
This monoclonal antibody–related article is a stub. You can help Wikipedia by adding missing information. |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by adding missing information. |